Westinghouse to Provide Fuel to PSEG’s Salem Nuclear Generating Station Through Continued Partnership
Westinghouse Electric Company today announced that it has signed a nuclear fuel contract extension with PSEG, a major supplier of nuclear power in New Jersey, to continue providing fuel assemblies for both units at the Salem Nuclear Generating Station.
“Westinghouse has been the single-source fuel provider for PSEG’s Salem plant since its start of operations more than 40 years ago, and we are pleased to continue to support this important and long-standing customer through the delivery of safe, reliable high-performance fuel,” said David Howell, president, Americas Region, and chief growth officer at Westinghouse. “This continued partnership is recognition of our reliable fuel performance and confirmation of the important trust PSEG has in Westinghouse.”
Under the terms of the contract, Westinghouse will deliver its 17x17 Robust Fuel Assemblies, known as RFA-2. The design of RFA-2 utilizes proven Robust Fuel Assembly™ technology, which has been used successfully in more than 25,000 assemblies at 62 plants over the past 19 years.
“We are proud to supply our customers with fuel that provides value to both their Salem units so that they can keep the plant running safely, efficiently and economically. Salem’s use of RFA-2 fuel assemblies can help to lower cycle costs and maintain high-quality performance – ultimately providing safe, clean and dependable energy for the people of New Jersey and the greater Delaware Valley,” said Michele DeWitt, senior vice president, Westinghouse Nuclear Fuel.
The RFA-2 fuel assemblies for the Salem Nuclear Generating Station will continue to be manufactured at Westinghouse’s Columbia Fuel Fabrication Facility in Columbia, South Carolina.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
JAPAN-CONTENT-SHOWCASE20.11.2017 04:02 | pressemeddelelse
Record Attendance at Japan Content Showcase 2017!
SHELL/BIO-BEAN20.11.2017 01:03 | pressemeddelelse
Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses
SAMSUNG-BIOEPIS19.11.2017 23:23 | pressemeddelelse
Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®
FOCP19.11.2017 17:33 | pressemeddelelse
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life
ASTRAZENECA19.11.2017 00:02 | pressemeddelelse
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases
ASTRAZENECA18.11.2017 19:22 | pressemeddelelse
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum